» Articles » PMID: 33373652

Prior SARS-CoV-2 Infection is Associated with Protection Against Symptomatic Reinfection

Overview
Journal J Infect
Date 2020 Dec 29
PMID 33373652
Citations 63
Authors
Affiliations
Soon will be listed here.
Citing Articles

Chronic active Epstein-Barr virus infection with reinfection of SARS-CoV-2: a case report.

Wu H, Liu L, Qu J, Wang C, Shi X, Lei Y Virol J. 2024; 21(1):142.

PMID: 38910238 PMC: 11194969. DOI: 10.1186/s12985-024-02418-7.


Initial COVID-19 severity influenced by SARS-CoV-2-specific T cells imprints T-cell memory and inversely affects reinfection.

Yang G, Cao J, Qin J, Mei X, Deng S, Xia Y Signal Transduct Target Ther. 2024; 9(1):141.

PMID: 38811527 PMC: 11136975. DOI: 10.1038/s41392-024-01867-4.


Persistence of T-Cell Immunity Responses against SARS-CoV-2 for over 12 Months Post COVID-19 Infection in Unvaccinated Individuals with No Detectable IgG Antibodies.

Pitiriga V, Papamentzelopoulou M, Konstantinakou K, Vasileiou I, Sakellariou K, Spyrou N Vaccines (Basel). 2023; 11(12).

PMID: 38140169 PMC: 10747023. DOI: 10.3390/vaccines11121764.


Population-based study of the durability of humoral immunity after SARS-CoV-2 infection.

Peterhoff D, Wiegrebe S, Einhauser S, Patt A, Beileke S, Gunther F Front Immunol. 2023; 14:1242536.

PMID: 37868969 PMC: 10585261. DOI: 10.3389/fimmu.2023.1242536.


Risk of and duration of protection from SARS-CoV-2 reinfection assessed with real-world data.

Reynolds S, Kaufman H, Meyer 3rd W, Bush C, Cohen O, Cronin K PLoS One. 2023; 18(3):e0280584.

PMID: 36943829 PMC: 10045607. DOI: 10.1371/journal.pone.0280584.


References
1.
Addetia A, Crawford K, Dingens A, Zhu H, Roychoudhury P, Huang M . Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate. J Clin Microbiol. 2020; 58(11). PMC: 7587101. DOI: 10.1128/JCM.02107-20. View

2.
Stephens D, McElrath M . COVID-19 and the Path to Immunity. JAMA. 2020; 324(13):1279-1281. DOI: 10.1001/jama.2020.16656. View

3.
Iwasaki A . What reinfections mean for COVID-19. Lancet Infect Dis. 2020; 21(1):3-5. PMC: 7550040. DOI: 10.1016/S1473-3099(20)30783-0. View

4.
Callow K, Parry H, Sergeant M, Tyrrell D . The time course of the immune response to experimental coronavirus infection of man. Epidemiol Infect. 1990; 105(2):435-46. PMC: 2271881. DOI: 10.1017/s0950268800048019. View

5.
Hanrath A, van der Loeff I, Lendrem D, Baker K, Price D, McDowall P . SARS-CoV-2 Testing of 11,884 Healthcare Workers at an Acute NHS Hospital Trust in England: A Retrospective Analysis. Front Med (Lausanne). 2021; 8:636160. PMC: 7994756. DOI: 10.3389/fmed.2021.636160. View